Brief: Sonoma Pharmaceuticals Receives COVID-19 label claim approval for Nanocyn disinfectant in Australia
May 28 (Reuters) - Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS AND MICROSAFE GROUP ANNOUNCE THAT
NANOCYN® DISINFECTANT & SANITIZER HAS RECEIVED APPROVAL TO BE
ENTERED INTO THE AUSTRALIAN REGISTER OF THERAPEUTIC GOODS (ARTG)
FOR USE AGAINST COVID-19
Source text for Eikon: ID:nBw53jNY9a
Further company coverage: SNOA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing